G.S. Shankar received his Pharm.D. from Creighton University, Omaha, Nebraska and also holds a MS degree in Public Health from the University of North Carolina and a MS degree in clinical psychology from CSU . He is Board Certified in psychiatric pharmacotherapy and is Certified as a Pharmacist Clinician (PhC) by the New Mexico Board of Pharmacy. He is a “Fellow of the Australian College of Pharmacy Practice”. Before coming to Western University College of Pharmacy, he worked several years as treatment review consultant and Clinical Pharmacist with the California Department of Mental Health and has been a member of the statewide psychopharmacology advisory committee during that period. His research and publications have been primarily on metabolic complications of psychiatric pharmacotherapy. G.S. Shankar received his Pharm.D. from Creighton University, Omaha, Nebraska and also holds a MS degree in Public Health from the University of North Carolina and a MS degree in clinical psychology from CSU . He is Board Certified in psychiatric pharmacotherapy and is Certified as a Pharmacist Clinician (PhC) by the New Mexico Board of Pharmacy. He is a “Fellow of the Australian College of Pharmacy Practice”. Before coming to Western University College of Pharmacy, he worked several years as treatment review consultant and Clinical Pharmacist with the California Department of Mental Health and has been a member of the statewide psychopharmacology advisory committee during that period. His research and publications have been primarily on metabolic complications of psychiatric pharmacotherapy.

metabolic complications of psychiatric pharmacotherapy